PHARMACOECONOMIC ANALYSIS AND PRESCRIBING PATTERNS OF PATIENTS SUFFERING FROM ASTHMA IN A TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Asthma, Tertiary care hospital, Nebulizer, Pharmacoeconomics
Abstract
Asthma is the most common respiratory disease, but the information regarding the Pharmacoeconomics of this disease isn’t widely available. Pharmacoeconomics involves the study of medication-related costs in the prescription, diagnosis, and treatment of the disease. It also includes the study of the effects of these medication costs on the financial status of the patients. This helps in the reduction of medication-related costs. The present study was conducted to perform “Pharmacoeconomic Analysis and to study the prescribing patterns in patients suffering from Asthma in BBR Multispecialty Hospital, Balnagar, Hyderabad over a period of 3 months i.e., from December 2021 to February 2022. The primary objective was to perform pharmacoeconomic analysis in asthma patients. The secondary objective was to study the prescription patterns of asthma medication in a tertiary care hospital. This is a consecutive consent, purposive study conducted at BBR Multispecialty Hospital carried out for a period of 3 months from December 2021 to February 2022. All the patients meeting the inclusion and exclusion criteria were informed the details of the study, and consent were obtained. About 110 patients within the age group of 15-70 were collected. The suitable statistical analysis with Microsoft excels was done. The average cost per day of asthma was found to be 79 rupees for mild asthma patients, 432 rupees for moderate asthma patients, and 2161 rupees for severe asthma patients. Among these, the highest cost was found to be 120.4 rupees for Nebulizer Foracort and the least cost was found to be 9.04 rupees for Inhaler Airz FB. The overall healthcare costs can be reduced by evaluation and reassessment of pharmacoeconomic data from manufacturing to dispensing
References
2. Lange, P., Parner, J., Vestbo, J., Schnohr, P. & Jensen, G. A 15 year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339, 1194–1200 (1998).
3. Porsbjerg, C., Lange, P. & Ulrik, C. S. Lung function impairment increases with age of diagnosis in adult onset asthma. Respir. Med. 109, 821–827 (2015).
4. Custovic, A. To what extent is allergen exposure a risk factor for the development of allergic disease? Clin. Exp. Allergy 45, 54–62 (2015).
5. Amelink, M. et al. Severe adult-onset asthma: a distinct phenotype. J. Allergy Clin. Immunol. 132, 336–341 (2013).
6. Ledford, D. K. & Lockey, R. F. Asthma and comorbidities. Curr. Opin. Allergy Clin. Immunol. 13, 78–86 (2013).
7. Custovic, A. et al. EAACI position statement on asthma exacerbations and severe asthma. Allergy 68, 1520–1531 (2013).
8. Fu, L. et al. Natural progression of childhood asthma symptoms and strong influence of sex and puberty. Ann. Am. Thorac. Soc. 11, 939–944 (2014).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
T. Pavithra
Sri indu Institute of pharmacy, Sheriguda Ranga Reddy, 501510,Telangana,
India,
Abdul Haseeb TS
Senior Pharmacist, Pharmacy service Department, Johns Hopkins Aramco Healthcare, Dharan, Saudi Arabia
T. Naga Aparna
Associate Professor, Department of Pharmaceutics, Sri indu institute of Pharmacy, Hyderabad, Telangana, India
Rohit kumar
Assistant Professor, Department of Pharmacology, Sri indu institute of pharmacy
Konda Shravan Kumar
Professor, Department of Pharmaceutics, Vision college of Pharmaceutical sciences and research, Hyderabad, Telangana, India
Jaffer sadik
Associate Professor, Department of Pharmaceutics, Sri indu institute of Pharmacy, Hyderabad, Telangana, India